Acotec Scientific Holdings (HKSE:06669) Research & Development: HK$399.8 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:06669 Acotec Scientific Holdings Ltd HKSE:06669
76 GF Score
Price HK$6.37
GF Value HK$14.83
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Acotec Scientific Holdings Research & Development?

Acotec Scientific Holdings HKSE:06669 -0.47% 76 Research & Development is HK$399.8 Mil as of Dec. 2025. GuruFocus rates HKSE:06669 with a GF Score™ of 76/100 and a GF Value™ of HK$14.83 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Acotec Scientific Holdings's Research & Development for the six months ended in Dec. 2025 was HK$122.9 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was HK$399.8 Mil.

Acotec Scientific Holdings  (HKSE:06669) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Acotec Scientific Holdings Research & Development Related Terms

Acotec Scientific Holdings Research & Development Historical Data

* Premium members only.

The historical data trend for Acotec Scientific Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acotec Scientific Holdings Research & Development Chart

Acotec Scientific Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 173.00 205.25 207.90 231.44 236.04

Acotec Scientific Holdings Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 108.15 124.19 111.92 122.93 276.91
HKSE:06669
76GF Score
Acotec Scientific Holdings Ltd HKSE:06669
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Acotec Scientific Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$399.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of HK$399.8 Mil mean?
Acotec Scientific Holdings (HKSE:06669) has a Research & Development of HK$399.8 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Acotec Scientific Holdings and its competitors.
Is Acotec Scientific Holdings' Research & Development too high?
Acotec Scientific Holdings' current Research & Development is HK$399.8 Mil. Overall, Acotec Scientific Holdings has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Acotec Scientific Holdings' Research & Development compare to ABT and SYK?
Acotec Scientific Holdings' Research & Development of HK$399.8 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Acotec Scientific Holdings and its competitors. Acotec Scientific Holdings's current Research & Development is HK$399.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acotec Scientific Holdings stock overvalued right now?
Based on GuruFocus' analysis, Acotec Scientific Holdings (HKSE:06669) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$14.83, compared to a current price of HK$6.37 — trading 57.1% below its estimated fair value. The current Research & Development is HK$399.8 Mil. Acotec Scientific Holdings' overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Acotec Scientific Holdings (HKSE:06669), the current Research & Development is HK$399.8 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Acotec Scientific Holdings (HKSE:06669) Overvalued in 2026?

Based on GuruFocus' analysis, Acotec Scientific Holdings stock appears to be undervalued. The current stock price of HK$6.37 is trading 57.1% below its estimated GF Value™ of HK$14.83. GuruFocus considers Acotec Scientific Holdings to be Significantly Undervalued.

Key valuation signals for HKSE:06669:

  • Research & Development: HK$399.8 Mil
  • GF Value™: HK$14.83 vs. price of HK$6.37 (57.1% below fair value)
  • GF Score™: 76/100 with 4 warning signs

No single metric tells the full story. See the HKSE:06669 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Acotec Scientific Holdings Business Description

Other Exchanges 7W3:Germany
Address 16 North Hongda Road, 4-5th Floor, Building No. 1, Beijing Economic-Technological Development Area, Beijing, CHN
Acotec Scientific Holdings Ltd is a medical technology company, focusing on the research and development, and application of technology platforms in the field of vascular interventional treatment. Its product portfolio comprises Semi-compliant PTCA balloon (YAN), Coronary CTO Recanalization Balloon (RT-Zero), Coronary CTO Antegrade Micro-Catheter (Vericor-14), Coronary High-Pressure Balloon (YIYAN), Coronary CTO Retrograde Micro-Catheter (Vericor-RS), Cardiac Valve Balloon Dilation Catheter (RunFlow), etc., and also has various other products in its development pipeline. Geographically, the company generates a majority of its revenue from Mainland China, and the rest from other regions. The firm generates the majority of its revenue from sales to Domestic distributors.
76GF Score

Get the complete analysis for HKSE:06669

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$6.37
Price
HK$14.83
GF Value